August 23rd 2024, 3:59pm
By Nathan L. Scott, M.D.
Nathan L. Scott, M.D., provides a brief overview of the current guidelines for treatment of metastatic uveal melanoma, as well as what considerations go into choosing the appropriate treatment for it. This program was made possible with support from Immunocore.
August 23rd 2024, 3:52pm
Nathan L. Scott, M.D., discusses the risk of recurrence within diagnosed uveal melanoma patients. Uveal Melanoma Prognosis and Risk Stratification
August 23rd 2024, 3:44pm
Nathan L. Scott, M.D., details what tests a patient should expect if they wish to confirm a uveal melanoma diagnosis. This program was made possible with support from Immunocore.
Melody Burchett discusses how she educates patients who have been recently diagnosed with uveal melanoma. Resources for Patients With Newly Diagnosed Uveal Melanoma
August 23rd 2024, 3:41pm
Melody Burchett discusses her journey with uveal melanoma and the formation of A Cure in Sight. This program was made possible with support from Immunocore.
August 23rd 2024, 3:00pm
By Ashley Chan
From Danielle Fishel and Rick Steves announcing their diagnosis to the “Emily in Paris” star discussing her cancer experience, here’s what’s happening in the oncology space this week.
August 23rd 2024, 2:43pm
After a brief introduction, Nathan L. Scott, M.D., gives an overview of uveal melanoma, including the risk factors and ways to help prevent it. This program was made possible with support from Immunocore.
August 23rd 2024, 1:00pm
By Alex Biese
One expert explained why ‘it’s very important to know what’s going on’ with regard to new renal cell carcinoma treatments.
August 22nd 2024, 9:00pm
Androgen receptor pathway inhibitors were shown to better treat patients with metastatic castration-resistant prostate cancer and improved survival.
August 22nd 2024, 7:00pm
By Brielle Benyon
Researchers investigated the incidence of moderate to severe side effects for patients being treated with a combination of TKI and immunotherapy.
August 22nd 2024, 5:00pm
By Felicia Mitchell
If you have lymphedema after breast cancer and want to enjoy the company of cats, there are strategies to avoid potential problems, especially scratches.
August 22nd 2024, 3:00pm
Afinitor did not improve relapse-free survival in patients with non-clear cell renal cell carcinoma — a kidney cancer subtype linked to poor prognosis.
August 22nd 2024, 1:00pm
By Felicia S. Johnson
Chemotherapy-related baldness pressured my strained self-identity. Was I the same person?
August 21st 2024, 8:10pm
By Jorge E. Cortes, MD
Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.
August 21st 2024, 8:03pm
Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.
The Seasons of Cancer
What Patients With Lung Cancer Need to Know About KRAS G12C Mutations
Ivonescimab Plus Chemo Delays NSCLC Progression
Standing Up to Cancer on My Own Two Feet